ESR1 and neoplasm: In fact, NF-κB is often hyperactivated in cancer cells, and this was corroborated here, since, unlike the non-tumor breast cells, both ER+ and ER– breast cancer cell lines exhibited high levels of NF-κB activation (Figure 5B).